medical writer 3
A recent study published in Arthritis Research and Therapy revealed that the CRP-Albumin-Lymphocyte Index (CALLYI) demonstrated significant potential as a biomarker for predicting osteoarthritis risk …
A comprehensive safety analysis of bimekizumab (BKZ) demonstrated good long-term tolerability and consistent safety outcomes in patients with axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA), …
A groundbreaking French multicenter study shed new light on how pregnancy affects disease activity in patients with rheumatoid arthritis (RA) and spondyloarthritis (SpA). The GR2 …
A Phase 2 trial exploring the novel microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitor vipoglanstat in patients with systemic sclerosis-related Raynaud’s phenomenon (RP) did not meet its primary …
A recent multicenter clinical trial published in JAMA Network has demonstrated that incorporating mycophenolate mofetil (MMF) into the standard treatment regimen significantly reduces the risk …
A recent study published in Annals of Rheumatic Diseases has revealed pivotal role of the caspase recruitment domain-containing protein 9 (CARD9) /neutrophil signaling axis in …
In a breakthrough for the treatment of systemic lupus erythematosus (SLE), a novel fusion protein, telitacicept, has shown significant promise in reducing disease activity and …
A new study, EDITA-ON, published in Arthritis Research & Therapy has found that continued treatment with ambrisentan significantly lowers the risk of developing pulmonary arterial …
A recent post hoc analysis published in The Journal of Rheumatology showed that TOF significantly improved efficacy compared to placebo across various baseline CRP levels. …